The interim Minister of Public Health, José Luis Satdjian, and the director of the National Agency for Research and Innovation (ANII), Pablo Caputi, presented this Thursday the 26th a new edition of the Health Fund in Clinical Research. The selected projects may receive up to 1,800,000 pesos as a non-refundable subsidy.
The activity, held in the Los Nogales room of the Technological Laboratory of Uruguay (LATU), was attended by researchers Javier Hurtado, Gonzalo Greif, Fernando Rodríguez, Nicolás Nin and Mónica Pujadas, users of the support granted by the Health Sector Fund in previous editions .
Satdjian highlighted the importance of carrying out research, because it implies medical advances that later result in a benefit for the entire population. In this sense, he highlighted the role of epidemiological research and clinical innovation during the COVID-19 pandemic.
He explained that the fund promotes projects that focus on health care, incorporate high technology and can generate concrete advances and be applied to health management in the short term.
For his part, Pablo Caputi reported that this time each selected project will receive up to 1,800,000 pesos as a non-refundable subsidy. In the case of an academic initiative, 100% is granted and, if it is presented by private companies or institutions, up to 50% of the amount is granted.
The hierarch specified that Uruguay can be highlighted in two major areas of innovation: information and communication technologies and the so-called life sciences. As he considered, according to the concept of “one health”: human, animal and environmental, this fund seeks to promote research in human health to have an impact on all.
The call will be open until Thursday, July 7, 2022 and applications are received at anii.org.uy
On the occasion, the speakers presented papers on pulmonary tuberculosis, synergy between the clinic and the laboratory, the search for markers, prognosis of severe tuberculosis, the value of clinical autopsy today, the role of biomarkers in acute lung injury and the importance of finance clinical research in Uruguay.